Comparison of free and liposome encapsulated doxorubicin tumor drug uptake and antitumor efficacy in the SC115 murine mammary tumor

Cancer Letters

Volumn 53, Issue 2-3, 1990, Pages 183-190

  Mayer, L D ^a,b   Bally, M B ^a,b   Cullis, P R ^a,b   Wilson, S L ^a   Emerman, J T ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Department of Anatomy University of British Columbia ^*  (Canada)

Author keywords

antitumor efficacy; liposomal doxorubicin; tumor drug uptake

Indexed keywords

DOXORUBICIN; LIPOSOME;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; DRUG UPTAKE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; LIPOSOMES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; SUPPORT, NON-U.S. GOV'T;

ANIMALIA; MURINAE;

EID: 0025007773     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(90)90212-G     Document Type: Article

References (23)

1. Analysis of the effect of liposomes encapsulation on the vesicant properties, acute and cardiac toxicity and antitumor efficacy of doxorubicin
2. Liposomes with entrapped doxorubicin exhibit extended blood residence times
3. Classification of dependent and autonomous variants of Shionogi mammary carcinoma based on heterogenous patterns of androgen binding
4. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy
5. Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity
6. Liposomes as in vivo carriers of adriamycin: Reduced cardiac uptake and preserved antitumor activity in mice
7. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers
8. Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model
9. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors
10. The use of cultured mammary tumor cells to study effects of steroid hormones
11. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient
12. Vesicles of variable size produced by a rapid extrusion procedure
13. Influence of vesicle size, lipid composition and drug-to-lipid ratio on the biological activity of liposomal doxorubicin
14. The use of liposomes as carriers of therapeutic agents
15. Effects of liposome-entrapped doxorubicin on liver metastases of mouse colon carcionomas 26 and 28
16. An androgen-dependent mouse mammary tumor
17. Effects of estrogens and antiestrogens on androgen-dependent growth of Shionogi carcinoma 115: role of estrogen receptor
18. Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes
19. Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes
20. Pharmacological, toxicological and therapeutic evaluation in mice of doxorubicin entrapped liposomes
21. Kinetic parameters and growth curves for experimental tumor systems
22. Reduced cardiotoxicity and nephrotoxicity with preservation of anti-tumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl Rat
23. Stimulatory effects of dexamethasone and indomethacin on growth of androgen-dependent Shionogi carcinoma 115 in the mouse